Experience

ONK Therapeutics

• Ireland
• Biotechnology Research
• 1 - 100 Employee

• Senior Manager, Program Management & Competitive Intelligence

  • Feb 2023 - Present

  County Galway, Ireland

• R&D Program Manager

  • Feb 2021 - Jan 2023

  County Galway, Ireland ONK Therapeutics is a biotechnology company developing off-the-shelf, CRISPR/Cas9 gene edited natural killer cell therapies for cancer. ONK raised a $21.5M Series A round in January 2022 from investors including Acorn Bioventures, ALSHC, and Cormorant Asset Management.



AveXis, Inc. (Novartis Gene Therapies)

• Senior Project Manager, Supply Chain EMEA

  • Jun 2020 - Jan 2021

  Dublin, Ireland

• Senior Project Manager, Technical Operations

  • Feb 2019 - May 2020

  Chicago, Illinois AveXis (acquired by Novartis) is a commercial gene therapy company developing and delivering novel treatments for patients with rare neurological diseases. In 2019, AveXis received FDA approval for Zolgensma, the first gene therapy for the treatment of SMA.



Structured Immunity

• Co-Founder

  • Aug 2017 - Jan 2019

  Notre Dame, Indiana and Chicago, Illinois Structured Immunity is a spin-out biotechnology company from the University of Notre Dame. The company leverages computational and structural biology to accelerate and de-risk the development of T cell therapies for cancer.